These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27541998)

  • 1. Lysobacter species: a potential source of novel antibiotics.
    Panthee S; Hamamoto H; Paudel A; Sekimizu K
    Arch Microbiol; 2016 Nov; 198(9):839-45. PubMed ID: 27541998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive natural products from Lysobacter.
    Xie Y; Wright S; Shen Y; Du L
    Nat Prod Rep; 2012 Nov; 29(11):1277-87. PubMed ID: 22898908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indole-Induced Reversion of Intrinsic Multiantibiotic Resistance in Lysobacter enzymogenes.
    Han Y; Wang Y; Yu Y; Chen H; Shen Y; Du L
    Appl Environ Microbiol; 2017 Sep; 83(17):. PubMed ID: 28625984
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of the Biosynthetic Gene Cluster for the anti-MRSA Lysocins through Gene Cluster Activation Using Strong Promoters of Housekeeping Genes and Production of New Analogs in
    Yu L; Du F; Chen X; Zheng Y; Morton M; Liu F; Du L
    ACS Synth Biol; 2020 Aug; 9(8):1989-1997. PubMed ID: 32610008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural products as a source of drug leads to overcome drug resistance.
    Silver LL
    Future Microbiol; 2015; 10(11):1711-8. PubMed ID: 26517443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotics from neglected bacterial sources.
    Pidot SJ; Coyne S; Kloss F; Hertweck C
    Int J Med Microbiol; 2014 Jan; 304(1):14-22. PubMed ID: 24120363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis, regulation, and engineering of natural products from
    Yue H; Miller AL; Khetrapal V; Jayaseker V; Wright S; Du L
    Nat Prod Rep; 2022 Apr; 39(4):842-874. PubMed ID: 35067688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative resistomic analyses of Lysobacter species with high intrinsic multidrug resistance.
    Yu M; Zhao Y
    J Glob Antimicrob Resist; 2019 Dec; 19():320-327. PubMed ID: 31100502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the omics era on the knowledge and use of Lysobacter species to control phytopathogenic micro-organisms.
    Puopolo G; Tomada S; Pertot I
    J Appl Microbiol; 2018 Jan; 124(1):15-27. PubMed ID: 28992371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actinomycetes: still a source of novel antibiotics.
    Genilloud O
    Nat Prod Rep; 2017 Oct; 34(10):1203-1232. PubMed ID: 28820533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-guided Investigation of Antibiotic Substances produced by Allosalinactinospora lopnorensis CA15-2(T) from Lop Nor region, China.
    Huang C; Leung RK; Guo M; Tuo L; Guo L; Yew WW; Lou I; Lee SMY; Sun C
    Sci Rep; 2016 Feb; 6():20667. PubMed ID: 26864220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indole Reverses Intrinsic Antibiotic Resistance by Activating a Novel Dual-Function Importer.
    Wang Y; Tian T; Zhang J; Jin X; Yue H; Zhang XH; Du L; Bai F
    mBio; 2019 May; 10(3):. PubMed ID: 31138746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete genome sequence and expression profile of the commercial lytic enzyme producer Lysobacter enzymogenes M497-1.
    Takami H; Toyoda A; Uchiyama I; Itoh T; Takaki Y; Arai W; Nishi S; Kawai M; Shin-Ya K; Ikeda H
    DNA Res; 2017 Apr; 24(2):169-177. PubMed ID: 28065880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural product discovery: past, present, and future.
    Katz L; Baltz RH
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):155-76. PubMed ID: 26739136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approaches to antimicrobial discovery.
    Lewis K
    Biochem Pharmacol; 2017 Jun; 134():87-98. PubMed ID: 27823963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Lysobacter enzymogenes ssp. cookii ' Christensen 1978 should be recognized as an independent species, Lysobacter cookii sp. nov.
    Kawamura Y; Tomida J; Morita Y; Naka T; Mizuno S; Fujiwara N
    FEMS Microbiol Lett; 2009 Sep; 298(1):118-23. PubMed ID: 19659731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new type of tripropeptin with anteiso-branched chain fatty acid from Lysobacter sp. BMK333-48F3.
    Hashizume H; Igarashi M; Sawa R; Adachi H; Nishimura Y; Akamatsu Y
    J Antibiot (Tokyo); 2008 Sep; 61(9):577-82. PubMed ID: 19160527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hfq regulates antibacterial antibiotic biosynthesis and extracellular lytic-enzyme production in Lysobacter enzymogenes OH11.
    Xu G; Zhao Y; Du L; Qian G; Liu F
    Microb Biotechnol; 2015 May; 8(3):499-509. PubMed ID: 25683974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterocyclic Aromatic N-Oxidation in the Biosynthesis of Phenazine Antibiotics from Lysobacter antibioticus.
    Zhao Y; Qian G; Ye Y; Wright S; Chen H; Shen Y; Liu F; Du L
    Org Lett; 2016 May; 18(10):2495-8. PubMed ID: 27145204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. David and Goliath: chemical perturbation of eukaryotes by bacteria.
    Ho LK; Nodwell JR
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):233-48. PubMed ID: 26433385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.